Global Negative Pressure Wound Therapy (NPWT) Devices Market- Drivers
Increasing prevalence of chronic wounds and ulcers among the global population is expected to drive the growth of the global negative pressure wound therapy (NPWT) devices market during the forecast period.
For instance, according to an article published in the National Library of Medicine, on October 5, 2020, titled “The Incidence of Pressure Ulcers and its Associations in Different Wards of the Hospital: A Systematic Review and Meta-Analysis,” it is estimated that about 2.5 million hospitalizations annually in the U.S. are due to pressure ulcers. Moreover, in the U. S., about US$ 11 billion is spent annually by the healthcare system for the prevention and treatment of pressure ulcers.
Increase in the prevalence of diabetes is expected to the drive the market growth over the forecast period.
For instance, according to the World Health Organization (WHO), as of September 16, 2022, 422 million people globally have diabetes, and the prevalence has been rising more rapidly in low- and middle-income countries than in high-income countries. In 2019, diabetes and kidney disease due to diabetes caused an estimated 2 million deaths, globally.
Global Negative Pressure Wound Therapy (NPWT) Devices Market: Restraint
The major factors that hinder growth of the global negative pressure wound therapy (NPWT) devices market include product recall and complications caused due to NPWT devices. For instance, on December 2, 2021, the government of Canada announced the recall of Avelle Negative Pressure Wound Therapy Pump manufactured by Convatec Inc., a medical products and technologies company, due to the manufacturing defects.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients